Newsletter | July 10, 2024

07.10.24 -- Earlier Market Access Planning


Bioprocess Online is excited to introduce Bio-Expo Live, a series of live virtual events designed to empower biopharma professionals with the chance to conveniently explore the newest equipment and offerings in Upstream Bioprocessing, Downstream Bioprocessing and Bioprocess Quality, Data, and Analytical Solutions. Registration is free, reserve your spot today!


Patient Access Challenges Are Changing Pharma Investment Strategies

Downward pressure on drug prices is causing biopharmaceutical companies to focus more time and energy on market access strategies — such as coverage and reimbursement scenario mapping, evidence generation, and resource development planning — much earlier in product development.


The Sponsor's Clinical Development Handbook For Gene Therapy Clinical Trials

Gene therapy has existed for decades, but the field is not as mature as it may seem. Its unique pace, structure, and funding dynamics present distinct challenges. Discover essential insights and strategies for overcoming gene therapy development challenges.


PBPK Modeling For Optimized Controlled Release Formulation Development

Examine the benefits of controlled release, the application of PBPK modeling in controlled release formulation development, and how modified release products can deliver optimal patient outcomes.

What Happened At ASCO 2024

Discover our associates' insights on the key developments from American Society of Clinical Oncology 2024 that are set to shape the future of cancer care and patient outcomes.

Exploring The Principles Integral To Rare Disease Drug Development

This on-demand webinar offers valuable insights into successful rare disease drug development, including study design, regulatory engagement, and market access strategy.

Solid Form Strategies For Increasing Oral Bioavailability

Optimizing a drug’s solid form can improve its solubility and bioavailability when further molecular modifications are prohibitive.

Explore The Nation's Preeminent Life Sciences Hub

Middlesex County, NJ, is a hotbed for the life sciences, offering a deep talent pool, an extensive R&D presence, and dedicated backing by local government in the form of strategic investment.